30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Goddard Glenn

Insider profile

Performance

Overall performance
3.6

Performance over holding periods
3.6
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Goddard Glenn's trades of Intellia Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-01-05 2024-01-03 S Sale
50,531 -9.1%
146.48
US$570,207
50,531 -9.1% 146.48 US$570,207
2023-01-06 2023-01-04 S Sale
43,541 -12.5%
157.28
US$1,319,784
43,541 -12.5% 157.28 US$1,319,784
2022-03-03 2022-01-01 S Sale
29,175 -15.2%
159.02
US$2,288,421
29,175 -15.2% 159.02 US$2,288,421
2021-09-01 2021-08-31 PlS Planned sale
24,800 -100.0%
160.22
US$3,973,456
24,800 -100.0% 160.22 US$3,973,456
2021-09-01 2021-08-30 PlS Planned sale
300 -100.0%
160.84
US$48,252
300 -100.0% 160.84 US$48,252
2021-09-01 2021-08-30 PlS Planned sale
300 -50.0%
159.53
US$47,859
300 -50.0% 159.53 US$47,859
2021-09-01 2021-08-30 PlS Planned sale
300 -33.3%
158.42
US$47,526
300 -33.3% 158.42 US$47,526
2021-09-01 2021-08-30 PlS Planned sale
496 -35.5%
157.33
US$78,036
496 -35.5% 157.33 US$78,036
2021-09-01 2021-08-30 PlS Planned sale
300 -17.7%
156.10
US$46,830
300 -17.7% 156.10 US$46,830
2021-09-01 2021-08-30 PlS Planned sale
1,700 -50.1%
155.29
US$263,993
1,700 -50.1% 155.29 US$263,993
2021-09-01 2021-08-30 PlS Planned sale
1,100 -24.5%
154.29
US$169,719
1,100 -24.5% 154.29 US$169,719
2021-09-01 2021-08-30 PlS Planned sale
704 -13.5%
153.22
US$107,867
704 -13.5% 153.22 US$107,867